Paroxetine Tablet, Film Coated
Product Images NDC 68788-4130

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 68788-4130). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Paroxetine Tab Usp 20mg (Image 04)

Label for Paroxetine tablets, USP 20 mg, film-coated oral tablets. The label states the product is generic for Paxil and manufactured by Zhejiang Huahai Pharmaceutical Technology Co. Ltd. It includes storage instructions and caution about federal law restricting transfer of the drug. Labels in both English and Spanish provide directions for tablet dosage and frequency. Manufacturer and some lot/product information fields are present but not filled.*

FDA Label Image

Picture1 (Image 05)

Chemical structure of paroxetine hydrochloride hemihydrate, the active ingredient in the Paroxetine 20 mg film-coated tablet by Preferred Pharmaceuticals Inc. The diagram shows the molecular connections and key atoms of the compound.*

FDA Label Image

Figure (Image 06)

A scatter plot chart showing the fold change and 90% confidence intervals of pharmacokinetic parameters (Cmax and AUC) for various interacting drugs (Pimozide, Desipramine, Propranolol, Digoxin, Phenytoin) compared to a reference, with a logarithmic x-axis labeled 'Change relative to reference' ranging from 0.1 to 10.0.*

FDA Label Image

Figure2 (Image 07)

A pharmacokinetic chart depicting fold change and 90% confidence intervals for Cmax and AUC of interacting drugs, including Cimetidine 300 mg, Phenobarbital 100 mg, Phenytoin 300 mg, Digoxin 0.25 mg, and Diazepam 5 mg, compared to a reference.*

FDA Label Image

Figure 3 (Image 08)

A chart depicting pharmacokinetic fold change and 90% confidence intervals of Paroxetine relative to a reference population. It includes data for populations with mild, moderate, and severe renal impairment, hepatic impairment, elderly patients at different doses, and males. Variables shown are Cmax, Cmin, and AUC, with change relative to reference on a logarithmic scale from 0.5 to 50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.